Lasa Supergenerics Limited — Others, 01-08-2025: Shareholders meeting

Lasa Supergenerics is seeking shareholder approval for the appointment of Mr. Prathamesh Chalke as Executive Director for a five-year term starting May 21, 2025. Mr. Chalke brings deep expertise in pharmaceutical production and has been integral to the company's daily operations for several years. The Board supports his appointment, believing his continued leadership will strengthen operational efficiency. Shareholders can cast their votes via remote e-voting from August 3 to September 2.